Eagle Pharmaceuticals, Inc. (EGRX)
Market Closed
12 Jun, 20:00
OTC PINK OTC PINK Primary $
0. 61
0
0%
$
8.03M Market Cap
- P/E Ratio
- Div Yield
435 Volume
- Eps
$ 0.61
Previous Close Want to track EGRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.98 | - |
| | | 1.01 | - |
| | | 1.09 | - |
| | | 0.61 | 0.73 |
| | | 0.71 | 0.8 |
| | | - | - |
| | | 0.3 | 0.07 |
| | | - | - |
| | | - | - |
| | | 1.47 | 1.31 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
EGRX Earnings Reports FAQ
What is the earnings per share (EPS) for EGRX?
EPS data for EGRX is currently not available, as Eagle Pharmaceuticals, Inc has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately -44.27%, reflecting the EGRX's performance and OTC PINK market conditions.
When is the next earnings release date?
Eagle Pharmaceuticals, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Eagle Pharmaceuticals, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for EGRX at this time, as Eagle Pharmaceuticals, Inc has no recent EPS data to calculate it.
